Skip to main content
Premium Trial:

Request an Annual Quote

GEDmatch Opts Out

GEDmatch changed its terms and conditions over the weekend to opt its users out of being a part of law enforcement searches, New Scientist reports. It adds, though, that users can opt in to being a part of such searches if they wish.

The database has been a key tool in a number of recent genetic genealogy-based arrests, including the Golden State Killer case. But it has also raised a number of privacy concerns. Last May, GEDmatch changed its terms and conditions to note that that law enforcement could upload DNA as part of an investigation into a homicide or sexual assault, or to identify human remains.

But now it has now revised them again, according to New Scientist. This, it reports, comes on the heels of the firm making an exception to its homicide or sexual assault clause to allow Utah police to search its site in the case of a 71-year-old woman who had been beaten.

This shift toward opting in places the field on sturdier ethical ground, writes the Legal Genealogist, Judy Russell, at her blog, as now users will make an informed choice to be part of searches.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.